The number of cases of the acquired immunodeficiency syndrome (AIDS) in the United Kingdom continues to rise; by May 1984 it was 47.' There is a high incidence of opportunistic lung infection in these patients and it is likely that the management of AIDS associated pneumonia will become an increasing problem in Britain. The organism most frequently identified in the United States is Pneumocystis carinii, which in one large series was found to be present in half the cases.2 Pneumocystis pneumonia in patients with AIDS may be rapidly progressive, with. a mortality rate of 40% despite treatment. 3 Bronchoalveolar lavage has been used to obtain diagnostic material in suspected opportunistic chest infection, both in iatrogenically immunosuppressed patients4 and in patients with AIDS.5 We present our findings from bronchoalveolar lavage and transbronchial biopsy in the first five patients with AIDS associated pneumonia seen at the Middlesex Hospital.
Methods
Five patients with AIDS in whom a lower respiratory tract infection was suspected on clinical and radiological grounds underwent transnasal fibreoptic bronchoscopy under intravenous sedation. Bronchoscopy was performed before the commencement of antibiotic treatment in four patients. Precautions similar to those used to prevent transmission of hepatitis B virus were taken by the operator. Topical lignocaine spray was applied to the nasopharynx, vocal cords, and carina. After insertion of the bronchoscope sterile suction apparatus was connected for the collection of specimens. The bronchoscope was wedged into the segmental bronchus that corresponded to the area of maximum radiological shadowing. Three 20 ml aliquots of warmed, sterile 0 9% saline were instilled into the segmental bronchus and immediately reaspirated. Transbronchial biopsy specimens were subsequently obtained from the same bronchopulmonary segment (four patients). The specimens were immediately taken to the microbiology laboratory, where the aspirated fluid was centrifuged and the biopsy material ground. Smears of the ground biopsy specimens and centrifuged deposit were prepared and stained with Gram's stain, auramine, Grocott' s stain, and Bronchoalveolar lavage and transbronchial biopsy in AIDS pneumonia The cause of AIDS is unknown, but the transmission of the disease appears to follow an epidemiological pattern similar to that of hepatitis B6 and a viral cause is therefore suspected. The New England Journal of Medicine has recommended that measures consistent with those suggested for the prevention of hepatitis B are used when dealing with AIDS patients.7 While performing these bronchoscopies we have therefore worn gloves, gowns, masks, and goggles as coughing can cause nasopharyngeal secretions to be sprayed into the eye of the operator through the endoscope suction channel. We have additionally set aside a bronchoscope for exclusive use in patients with suspected AIDS, as although we follow a special sterilisation procedure after each examination we do not think this instrument should be used in other patients. We have been unable to use other equipment-for example, for the measurement of carbon monoxide transfer factor in case 1 to help to establish whether the pulmonary shadowing was the result of i.itra-alveolar haemorrhage, infection, or oedema-because of our inability to subject it to adequate sterilisation procedures.
The optimum timing of bronchoscopy in these patients with suspected opportunistic lung infection is not clear. We have withheld the procedure from patients with a dry cough until there were clinical or radiological signs of a lower respiratory tract infection, but a recent series from the United States reported the presence of Pneumocystis carinii in bronchoalveolar lavage fluid in eight of 25 patients with AIDS who had a dry cough but a normal chest radiograph. The arterial Po2 was found to be reduced in these patients, despite the normal chest radiograph.8 It may therefore be necessary to perform more frequent estimations of blood gas tensions and consider bronchoscopy if the Pao2 falls. Possibly the very rapid clinical and radiological deterioration which can occur in pneumocystis pneumonia would be in part prevented by earlier therapeutic intervention. By contrast, Venet et a15 identified Pneumocystis carinii in the lavage aspirate only of those patients in whom the chest radiograph was abnormal. Additionally, this group has reported Swinburn, Pozniak, Sutherland, Banks, Teall, Johnson the persistence of Pneumocystis carinii in the lavage aspirate three weeks after high dose co-trimoxazole treatment and a return to normal of the chest radiograph, from which they inferred that the presence of this organism may not always be an indication for treatment. We failed to identify Pneumocystis carinii in the bronchoalveolar lavage aspirates, but positively identified it in the transbronchial biopsy specimens from two patients. This finding is in agreement with early reports from the United States, in which the diagnostic yield of Pneumocystis carinii was higher from transbronchial biopsy than bronchoalveolar lavage specimens.9 Possibly therefore Pneumocystis carinii was present in patient 1, in whom transbronchial biopsy was not performed. We have cultured many other organisms from the lavage aspirates in all five cases. In general, fewer were cultured from the transbronchial biopsy specimens, and the organisms found there were also present in the lavage aspirates (table). Probably some of the organisms found in the lavage fluid were contaminants from the nasopharynx. Bartlett examined this problem in 16 patients undergoing diagnostic bronchoscopy in whom there was no clinical evidence of infection, and isolated an average of five bacterial organisms per lavage aspirate. Methylene blue dye sprayed into the pharynx of 10 of these patients immediately before bronchoscopy was visible in the lavage aspirate of eight patients. The authors concluded that nasopharyngeal contamination of the lavage aspirate was a potential source of misleading results.'0 Although the transbronchial biopsy specimens are withdrawn through the suction channel of the endoscope and are therefore not immune from contamination, we believe that the organisms isolated may be more representative of those responsible for infection. This consideration, together with our failure to identify Pneumocystis carinii in the bronchoalveolar lavage aspirates, suggests that transbronchial biopsy may offer a better guide to antimicrobial treatment. Necropsies were not performed on those patients who died in hospital because of the possible hazards to the pathologist.
We were therefore unable to obtain firmer evidence to support this suggestion.
The wide variety of organisms isolated from each patient led to treatment with many antimicrobial drugs, as it was not always clear which organism was the principal pathogen. Because Pneumocystis carinii has been reported as the organism most commonly responsible for pneumonia in these patients, we began treatment with high dose cotrimoxazole in four patients immediately after bronchoscopy (patient 5 was already receiving this treatment). This treatment was reported to cause potentially serious side effects in eight out of-28 patients with AIDS." Patient 1 developed a profound thrombocytopenia associated with possible intra-alveolar haemorrhage after 14 days of cotrimoxazole, which may have contributed to his clinical course. We feel that it may be inadvisable to continue this treatment if Pneumocystis carinii is not identified by all available means unless there are strong clinical grounds to suspect its presence. In this context it must be remembered that these patients may also develop more " conventional" infections, as exemplified by the pneumococcal lobar pneumonia in case 2.
In conclusion, we have experienced several difficulties in the management of these patients. The incidence-.--of AIDS associated pneumonia will almost certainly increase and further experience is required before these problems can be satisfactorily resolved and firm recommendations made. 
